Stocks
J&J Valuation Holds Steady Despite Lowered Earnings Forecast
Johnson & Johnson's stock finished Friday at $259.24, up 0.9% for the session and 1.1% for the week.
The company revised its earnings forecast for 2026 downward by 5.5%, citing deal expenses, but left revenue guidance unchanged.
Despite this adjustment, Johnson & Johnson's valuation remains high at 23.5 times the updated midpoint of adjusted earnings per share.
The consensus rating among analysts remains Overweight, with a mean price target of $277.81 representing a potential gain of 7.2%.